4//SEC Filing
SR One Capital Fund I Aggregator LP 4
Accession 0001209191-22-062226
CIK 0001807120other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 6:37 PM ET
Size
28.1 KB
Accession
0001209191-22-062226
Insider Transaction Report
Form 4
SR One Capital Fund I Aggregator LP
10% Owner
Transactions
- Purchase
Common Stock
2022-12-16$8.28/sh+500,000$4,140,550→ 6,126,476 total - Purchase
Common Stock
2022-12-19$8.63/sh+360,000$3,108,096→ 6,486,476 total - Purchase
Common Stock
2022-12-20$8.14/sh+40,000$325,432→ 6,526,476 total
SR ONE CAPITAL PARTNERS I, LP
10% Owner
Transactions
- Purchase
Common Stock
2022-12-19$8.63/sh+360,000$3,108,096→ 6,486,476 total - Purchase
Common Stock
2022-12-20$8.14/sh+40,000$325,432→ 6,526,476 total - Purchase
Common Stock
2022-12-16$8.28/sh+500,000$4,140,550→ 6,126,476 total
SR ONE CAPITAL MANAGEMENT, LLC
10% Owner
Transactions
- Purchase
Common Stock
2022-12-19$8.63/sh+360,000$3,108,096→ 6,486,476 total - Purchase
Common Stock
2022-12-16$8.28/sh+500,000$4,140,550→ 6,126,476 total - Purchase
Common Stock
2022-12-20$8.14/sh+40,000$325,432→ 6,526,476 total
Footnotes (4)
- [F1]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.76 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The securities are directly held by SR One Capital Fund I Aggregator, LP ("SR One Fund I Aggregator"). SR One Capital Partners I, LP ("SR One Partners I") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC ("SR One Capital Management") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management (SR One Partners I, SR One Capital Management, and Dr. George together, the "Indirect Reporting Persons"). The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), or otherwise of such portion of the securities held by SR One Fund I Aggregator in which the Indirect Reporting Persons have no pecuniary interest, and this report shall not be deemed an admission that the Indirect Reporting Persons are the beneficial owners of such securities for Section 16 or any other purpose.
- [F3]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.25 to $8.90 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.86 to $8.45 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001848319
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 6:37 PM ET
- Size
- 28.1 KB